Bill

Bill > S301


NJ S301

NJ S301
Classifies 7 Hydroxymitragynine as Schedule I drug.


summary

Introduced
01/13/2026
In Committee
01/13/2026
Crossed Over
Passed
Dead

Introduced Session

2026-2027 Regular Session

Bill Summary

This bill would classify 7 hydroxymitrgynine (7-OH) as a Schedule I controlled dangerous substance. 7-OH is one of the psychoactive alkaloids naturally found in the Mitragyna speciosa plant, commonly known as Kratom. 7-OH, in higher concentrations when metabolized by the body, can produce opioid-like effects and can have similarly addictive qualities. Kratom, which contains 7-OH in lower concentrations in its natural form, is frequently marketed for its psychoactive and opioid-like analgesic effects and for use in the treatment of certain opioid addictions and withdrawal symptoms, a treatment which has not been conclusively proven. The federal Food and Drug Administration (FDA) has advised that 7-OH poses a threat to public health and has the potential for abuse because of its ability to blind opioid receptors in the brain. The FDA has issued a number of warnings and conducted seizures of illegally sold, unapproved, or misbranded drug products containing potentially lethal doses of synthetic 7-OH, which contain higher concentrations of the psychoactive alkaloid. Currently, Kratom and 7-OH have not been approved by the FDA for any medical use. Further, on July 29, 2025, the FDA also recommended that 7-OH be scheduled under the federal "Controlled Substances Act," 21 U.S.C.s.812. Until the drug is scheduled under the federal act, 7-OH is not presently barred by federal law. It is also not presently barred by New Jersey law. Under this bill, 7-OH would be classified as a Schedule I drug in this State. 7-OH would be placed on the Schedule I list of the "New Jersey Controlled Dangerous Substances Act," P.L.1970, c.226 (C.24:21-1 et seq.), which would define the drug as a substance that: (1) has high potential for abuse; and (2) has no accepted medical use in treatment in the United States; or lacks accepted safety for use in treatment under medical supervision. By classifying 7-OH as a Schedule I drug, under the "Comprehensive Drug Reform Act of 1987," N.J.S.2C:35-1 et seq., the drug would be considered illegal controlled dangerous substances for which manufacturing, distribution, or possession with intent to manufacture or distribute would be punishable as either: a crime of the second degree, if the act involved a quantity of one ounce or more; or a crime of the third degree, if the act involved less than one ounce.

AI Summary

This bill would classify 7 Hydroxymitragynine, a psychoactive compound found in the plant Kratom, as a Schedule I controlled dangerous substance under New Jersey law, meaning it has a high potential for abuse and no currently accepted medical use in the United States or lacks accepted safety for use under medical supervision. This classification, which aligns with recommendations from the federal Food and Drug Administration (FDA) due to the drug's opioid-like effects and potential for addiction, would make the manufacturing, distribution, or possession with intent to distribute of 7 Hydroxymitragynine illegal, with penalties ranging from a second-degree crime for one ounce or more to a third-degree crime for less than one ounce.

Committee Categories

Health and Social Services

Sponsors (1)

Last Action

Introduced in the Senate, Referred to Senate Health, Human Services and Senior Citizens Committee (on 01/13/2026)

bill text


bill summary

Loading...

bill summary

Loading...

bill summary

Loading...